140 West 57th Street
Suite 3B
Cure Therapeutics Inc.
Cure Therapeutics hopes to help the millions of athletes and workers who suffer from tendonitis. The company is developing transdermally delivered nitric oxide drugs designed to lessen the pain and speed recovery from chronic musculoskeletal conditions like swimmer's shoulder, tennis elbow, jumper's knee, and Achilles tendonitis.
More from Archive
More from Scrip
• By
Deal Snapshot: Jazz, which sells Epidiolex for rare seizure disorders, will pay $42.5m up front to take over development of Saniona’s preclinical Kv7.2/Kv7.3 activator SAN2355 for epilepsy.
• By
Four days after Wegovy became the second approved MASH therapy in the US, Rezdiffra gets the first European approval. Plans are for an initial launch in Germany.
• By
All eyes on chronic urticaria after eosinophilic esophagitis disappointment.